This morning, One Madison Corp. (OMAD), released the details of their shareholder vote to approve their merger with Ranpak Corporation., and while the combination was strongly approved, there were a significant amount of redemptions.
Proposal to approve the business combination:
| FOR | AGAINST | ABSTAIN | Broker Non-Votes |
| 35,857,803 | 1,427,450 | 0 | 0 |
Only 1,427,450 shares voted against the transaction, but 15,418,654 shares opted to redeem which removed approximately $158 million from the nearly $308 million held in trust. The good news is, One Madison had $312 million in committed capital thanks to the $150 million backstop with their Anchor Investors (Blackstone) and $162 million in new PIPEs. The additional $150 million left in trust gives Ranpak approximately $462 million to work with going forward.
This business combination is expected to close on June 3rd, 2019, and Ranpak is expected to apply for continued listing on the NYSE under the symbols “PACK” and “PACK.WS,” for it’s common stock and warrants, respectively.
You can find the filed vote results for all One Madison’s proposals HERE.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...